Lexicon Pharmaceuticals Inc (LXRX)
0.8634
+0.09
(+11.88%)
USD |
NASDAQ |
Nov 22, 16:00
0.8755
+0.01
(+1.40%)
After-Hours: 20:00
Lexicon Pharmaceuticals Revenue (TTM): 5.229M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.229M |
| June 30, 2024 | 3.641M |
| March 31, 2024 | 2.311M |
| December 31, 2023 | 1.205M |
| September 30, 2023 | 0.531M |
| June 30, 2023 | 0.408M |
| March 31, 2023 | 0.126M |
| December 31, 2022 | 0.139M |
| September 30, 2022 | 0.125M |
| June 30, 2022 | 0.109M |
| March 31, 2022 | 0.308M |
| December 31, 2021 | 0.298M |
| September 30, 2021 | 0.483M |
| June 30, 2021 | 7.094M |
| March 31, 2021 | 16.02M |
| December 31, 2020 | 24.00M |
| September 30, 2020 | 32.52M |
| June 30, 2020 | 320.34M |
| March 31, 2020 | 320.86M |
| December 31, 2019 | 322.07M |
| September 30, 2019 | 330.42M |
| June 30, 2019 | 42.94M |
| March 31, 2019 | 47.05M |
| December 31, 2018 | 63.21M |
| September 30, 2018 | 80.54M |
| Date | Value |
|---|---|
| June 30, 2018 | 100.52M |
| March 31, 2018 | 98.77M |
| December 31, 2017 | 91.69M |
| September 30, 2017 | 76.24M |
| June 30, 2017 | 77.02M |
| March 31, 2017 | 85.06M |
| December 31, 2016 | 79.26M |
| September 30, 2016 | 187.58M |
| June 30, 2016 | 160.43M |
| March 31, 2016 | 140.72M |
| December 31, 2015 | 130.01M |
| September 30, 2015 | 24.22M |
| June 30, 2015 | 24.07M |
| March 31, 2015 | 24.37M |
| December 31, 2014 | 22.85M |
| September 30, 2014 | 2.782M |
| June 30, 2014 | 2.601M |
| March 31, 2014 | 2.139M |
| December 31, 2013 | 2.222M |
| September 30, 2013 | 1.03M |
| June 30, 2013 | 1.164M |
| March 31, 2013 | 1.149M |
| December 31, 2012 | 1.089M |
| September 30, 2012 | 1.214M |
| June 30, 2012 | 1.197M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.109M
Minimum
Jun 2022
322.07M
Maximum
Dec 2019
52.89M
Average
1.758M
Median
Revenue (TTM) Benchmarks
| Viatris Inc | 15.05B |
| Halozyme Therapeutics Inc | 947.36M |
| Perspective Therapeutics Inc | -- |
| Quanterix Corp | 127.95M |
| Autonomix Medical Inc | -- |